These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15124836)

  • 21. Depressed Corin Levels Indicate Early Systolic Dysfunction Before Increases of Atrial Natriuretic Peptide/B-Type Natriuretic Peptide and Heart Failure Development.
    Tripathi R; Wang D; Sullivan R; Fan TH; Gladysheva IP; Reed GL
    Hypertension; 2016 Feb; 67(2):362-7. PubMed ID: 26667411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
    Falcão LM; Pinto F; Ravara L; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):121-9. PubMed ID: 15526247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect.
    Muta H; Ishii M; Maeno Y; Akagi T; Kato H
    Acta Paediatr; 2002; 91(6):649-52. PubMed ID: 12162595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial natriuretic peptide as a marker of heart failure in children with left ventricular volume overload.
    Kotby AA; Taman KH; Sedky HT; Habeeb NM; El-Hadidi ES; Yosseif HS
    J Paediatr Child Health; 2013 Jan; 49(1):43-7. PubMed ID: 23279037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
    Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
    Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer.
    Hayakawa H; Komada Y; Hirayama M; Hori H; Ito M; Sakurai M
    Med Pediatr Oncol; 2001 Jul; 37(1):4-9. PubMed ID: 11466716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secretion of A-type and B-type natriuretic peptides into the bloodstream and pericardial space in children with congenital heart disease.
    Ootaki Y; Yamaguchi M; Yoshimura N; Oka S; Yoshida M; Hasegawa T
    J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1411-6. PubMed ID: 14666013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction.
    Matsumoto A; Hirata Y; Momomura S; Suzuki E; Yokoyama I; Sata M; Ohtani Y; Serizawa T
    Am Heart J; 1995 Jan; 129(1):139-45. PubMed ID: 7817907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of natriuretic peptides in children with various types of loading conditions.
    Eerola A; Jokinen E; Pihkala JI
    Scand Cardiovasc J; 2009 Jun; 43(3):187-93. PubMed ID: 18855222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.
    Loke I; Squire IB; Davies JE; Ng LL
    Eur J Heart Fail; 2003 Oct; 5(5):599-606. PubMed ID: 14607197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interventional catheterization decreases plasma levels of atrial natriuretic peptide (ANP) in children with congenital heart defects.
    Zeevi B; Gil-Ad I; Zabreski R; Berant M; Laron Z; Weizman A; Blieden LC
    Cathet Cardiovasc Diagn; 1998 Sep; 45(1):27-32. PubMed ID: 9736347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain and atrial natriuretic peptide plasma concentrations in normal healthy children.
    Ationu A; Carter ND
    Br J Biomed Sci; 1993 Jun; 50(2):92-5. PubMed ID: 8219925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy.
    Staudt A; Staudt Y; Hummel A; Empen K; Dörr M; Trimpert C; Birkenmeier K; Kühl U; Noutsias M; Russ D; Felix SB
    Ther Apher Dial; 2006 Feb; 10(1):42-8. PubMed ID: 16556135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma atrial natriuretic peptide levels in children with cardiac diseases: correlation with cGMP levels and haemodynamic parameters.
    Weil J; Strom TM; Brangenberg R; Sebening W; Haufe M; Lang RE; Bidlingmaier F; Gerzer R
    Horm Res; 1987; 28(1):64-70. PubMed ID: 2834283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of natriuretic Peptide levels to predict mortality in adults with congenital heart disease.
    Giannakoulas G; Dimopoulos K; Bolger AP; Tay EL; Inuzuka R; Bedard E; Davos C; Swan L; Gatzoulis MA
    Am J Cardiol; 2010 Mar; 105(6):869-73. PubMed ID: 20211335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
    Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T
    Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of natriuretic peptides in Chagas' disease: a 3-year follow-up investigation.
    Moreira Mda C; Heringer-Walther S; Wessel N; Moreira Ventura T; Wang Y; Schultheiss HP; Walther T
    Cardiology; 2008; 110(4):217-25. PubMed ID: 18073475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction on metabolic clearance between A-type and B-type natriuretic peptides in patients with heart failure.
    Yoshimura M; Mizuno Y; Harada E; Nakayama M; Shimasaki Y; Ito T; Nakamura S; Soejima H; Miyamoto S; Takazoe K; Ogawa H; Kugiyama K; Saito Y; Nakao K; Yasue H
    Metabolism; 2000 Sep; 49(9):1228-33. PubMed ID: 11016910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.